Track topics on Twitter Track topics that are important to you
WASHINGTON, July 27, 2015 (GLOBE NEWSWIRE) -- Abengoa Yield (NASDAQ:ABY), the sustainable total return company that owns a diversified portfolio of contracted assets in the energy and environment sectors, today announced its fourth asset acquisition:
Abengoa Yield has entered into a definitive agreement with Abengoa to acquire Solaben 1/6, a 100 MW solar complex in Spain, which has been in operation since 2013, showing a solid operational track record and synergies with our existing portfolio.
In addition, Abengoa Yield announced its first two acquisitions from third parties:
Total consideration amounts to $370 million and Abengoa Yield expects these new assets to generate incremental run rate cash available for distribution of approximately $31.5 million per year before debt service associated with acquisition financing. The acquisition will be financed with the revolving credit facility recently increased in $290 million and cash on hand. With this transaction, Abengoa Yield reaches total acquisitions of approximately $1.5 bn since its initial public offering at an average acquisition yield of approximately 9%.
Javier Garoz, CEO of Abengoa Yield, said "This fourth acquisition reinforces our consistent growth and shows a first acquisition form third parties of assets we know well. All our assets are showing strong operational performance providing solid results for the quarter that we will announce on July 30. We are glad to continue delivering on our commitments with our shareholders."
The transaction has been approved by Abengoa Yield's board of directors with the approval of independent directors. Solaben 1/6 and ATN2 transactions have been approved by Abengoa's board of directors.
About Abengoa Yield
Abengoa Yield is a total return company that owns a diversified portfolio of contracted renewable energy, power generation, electric transmission and water assets in North America, South America and EMEA. We focus on providing a predictable and growing quarterly dividend or yield to our shareholders (www.abengoayield.com).
This news release contains forward-looking statements. These forward-looking statements include, but are not limited to, all statements other than statements of historical facts contained in this prospectus, including, without limitation, those regarding our future financial position and results of operations, our strategy, plans, objectives, goals and targets, future developments in the markets in which we operate or are seeking to operate or anticipated regulatory changes in the markets in which we operate or intend to operate. In some cases, you can identify forward-looking statements by terminology such as "aim," "anticipate," "believe," "continue," "could," "estimate," "expect," "forecast," "guidance," "intend," "is likely to," "may," "plan," "potential," "predict," "projected," "should" or "will" or the negative of such terms or other similar expressions or terminology. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Our actual results of operations, financial condition and the development of events may differ materially from (and be more negative than) those made in, or suggested by, the forward-looking statements.
Factors that could cause actual results to differ materially from those contemplated above include, among others, general economic conditions, changes in government expenditure budgets, challenges in making acquisitions, changes in public support of renewable energy, weather conditions, legal challenges to regulations, changes to subsidies and incentives that support renewable energy sources, government regulations, the volatility of energy and fuel prices, counterparty credit risk, failure of customers to perform under contracts, our ability to enter into new contracts as existing contracts expire, reliance on third-party contractors and suppliers, failure of newly constructed assets to perform as expected, failure to receive dividends from assets, changes in our tax position, unanticipated outages at our generation facilities, the condition of capital markets generally, our ability to access capital markets, adverse results in current and future litigation and our ability to maintain and grow our quarterly dividends. Furthermore, any dividends are subject to available capital, market conditions, and compliance with associated laws and regulations. These factors should be considered in connection with information regarding risks and uncertainties that may affect Abengoa Yield's future results included in Abengoa Yield's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
Abengoa Yield undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or developments or otherwise.
CONTACT: CFO and COO Eduard Soler Tel: +34 954 93 71 11 E-mail: email@example.com Investor relations Leire Perez Tel: +34 954 93 71 11 E-mail: firstname.lastname@example.org Communication Department Patricia Malo de Molina Melendez. Tel: +34 954 93 71 11 E-mail: email@example.comNEXT ARTICLE
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...